Barriers and facilitators to using vaporised nicotine products as smoking cessation aids among people receiving treatment for substance use disorder

CONCLUSIONS: VNPs hold significant promise as smoking cessation aids among people in AOD treatment because of their unique ability to satisfy both nicotine cravings and behavioural habits. However, multiple barriers, such as accessibility, maintenance, and the challenges of reducing other substance use simultaneously also need to be addressed for optimal engagement in clinical trials with VNPs to quit smoking.PMID:34536632 | DOI:10.1016/j.addbeh.2021.107097

Source: Addictive Behaviors - September 18, 2021 Category: Addiction Authors: Alistair Lum Eliza Skelton Maryanne Robinson Ashleigh Guillaumier Olivia Wynne Coral Gartner Ron Borland Amanda Baker Adrian Dunlop Ross B Wilkinson Billie Bonevski Source Type: research